| Sandoz Pharmaceuticals AG - Tofacitinib Sandoz 5 mg, Filmtabletten | | 69483 | | 01 | | Tofacitinib Sandoz 5 mg | | Filmtabletten | | | | | | 19.02.2025 | | |
| | Composition | | tofacitinibum 5 mg ut tofacitinibi citras, cellulosum microcristallinum, lactosum monohydricum, carmellosum natricum conexum corresp. natrium 0.54 mg, magnesii stearas, Überzug: hypromellosum, E 171, lactosum monohydricum, macrogolum 3350, triacetinum, pro compresso obducto corresp. lactosum monohydricum 62.56 mg. | | Packungsbestandteile | | Coated tablets | | | | Active Agent | Dose |
|---|
| Tofacitinibum | 5 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | Hypromellosum | | Überzug | | Lactose Monohydrate | | | | Macrogol | 3350 | | | Magnesii Stearas | | | | Pro Compresso Obducto | | | | Triacetinum | | |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 56 | PR | PR | B | | No |
|
|
